| Financial Year |
March 31 2023 |
| Monetary Funds |
1,100,823,878.99 |
| Held-for-trading Financial Assets |
263,129,851.60 |
| Notes Receivable |
34,760,730.61 |
| Accounts Receivable |
1,119,801,340.06 |
| Advances to Suppliers |
61,452,146.54 |
| Other Receivables |
45,407,457.10 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
668,064,681.08 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
1,747,508.96 |
| Other Current Assets |
148,166,066.88 |
| Total Current Assets |
3,601,007,157.17 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
742,939,388.40 |
| Investment Properties |
211,014,334.86 |
| Fixed Assetes |
837,871,918.24 |
| Under-construction Projects |
1,335,288.72 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
125,815,612.01 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
10,157,109.35 |
| Deferred Income Tax Assets |
19,346,385.05 |
| Other Non-Current Assets |
11,754,417.40 |
| Sub-Total of Non-Current Assets |
1,972,838,219.97 |
| Total Assets |
5,573,845,377.14 |
| Short-Term Loans |
18,113,510.72 |
| Trading Financial liabilities |
-- |
| Notes Payable |
101,447,696.80 |
| Accounts Payable |
1,358,021,436.91 |
| Accounts Received In Advance |
302,014.54 |
| Employee Compensation Payable |
19,592,829.30 |
| Taxes Payable |
42,410,076.91 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
76,926,857.50 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
6,782,336.14 |
| Other Current Liabilities |
24,335,567.87 |
| Sub-Total of Current Liabilities |
1,722,101,168.05 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
4,761,432.61 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
61,303,617.78 |
| Total Liabilities |
1,783,404,785.83 |
| Paid-In Capital(Or Share Stock) |
913,838,529.00 |
| Capital Surplus |
1,470,691,800.13 |
| Surplus Reserve |
286,530,634.83 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
853,461,865.21 |
| Minority Stockholder's Interest |
265,967,071.93 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,524,473,519.38 |
| Owner's Equity（Stockholder's Equity） |
3,790,440,591.31 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,573,845,377.14 |
